Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.76M | 3.33M | 5.03M | 5.34M | 3.45M |
Total Receivables | 570.00K | 23.00K | 39.00K | 56.00K | 481.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 275.00K | 1.78M | 2.56M | 2.02M | 2.08M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 77.00K | 63.00K | 64.00K | 104.00K | 259.00K |
Total Current Assets | 2.69M | 5.20M | 7.70M | 7.52M | 6.27M |
|
|||||
Total Current Assets | 2.69M | 5.20M | 7.70M | 7.52M | 6.27M |
Net Property, Plant & Equipment | 20.00K | 27.00K | 35.00K | 263.00K | 278.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 14.00K | 49.00K | 35.26M | 82.57M |
Total Assets | 2.71M | 5.24M | 7.78M | 49.04M | 92.40M |
|
|||||
Total Accounts Payable | 221.00K | 1.56M | 482.00K | 2.26M | 2.69M |
Total Accrued Expenses | 588.00K | 1.31M | 2.31M | 400.00K | 400.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 28.00K | 37.00K | 40.00K | 50.00K | 49.00K |
Total Finance Division Other Current Liabilities | 36.00K | 98.00K | 46.00K | -- | -- |
Total Other Current Liabilities | 36.00K | 98.00K | 46.00K | -- | -- |
Total Current Liabilities | 873.00K | 3.01M | 2.88M | 2.71M | 3.14M |
|
|||||
Total Current Liabilities | 873.00K | 3.01M | 2.88M | 2.71M | 3.14M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 7.00K | 225.00K | 237.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.14M | 422.00K | 1.56M | 14.77M | 22.03M |
Total Liabilities | 2.01M | 3.43M | 4.45M | 17.71M | 25.40M |
|
|||||
Common Stock & APIC | 219.61M | 219.50M | 219.50M | 219.49M | 219.49M |
Retained Earnings | -242.33M | -240.97M | -239.32M | -210.07M | -170.69M |
Treasury Stock & Other | 24.13M | 23.99M | 23.84M | 22.57M | 18.86M |
Total Common Equity | 1.40M | 2.51M | 4.02M | 32.00M | 67.66M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.40M | 2.51M | 4.02M | 32.00M | 67.66M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -703.00K | -701.00K | -693.00K | -669.00K | -664.00K |
Total Equity | 695.00K | 1.81M | 3.33M | 31.33M | 67.00M |
|